ArticleClinical immunology (Orlando, Fla.)2014

Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.

Nicole L Regna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.